PT - JOURNAL ARTICLE AU - Weihang Li AU - Alan Micco AU - Deyu Fang AU - Huiping Liu TI - Intratympanic steroid treatments rescued recurrent hearing loss following COVID-19 vaccination and detection of an intralabyrinthine schwannoma AID - 10.1136/bcr-2022-249316 DP - 2022 Jul 01 TA - BMJ Case Reports PG - e249316 VI - 15 IP - 7 4099 - http://casereports.bmj.com/content/15/7/e249316.short 4100 - http://casereports.bmj.com/content/15/7/e249316.full SO - BMJ Case Reports2022 Jul 01; 15 AB - It remains unclear how to effectively treat rare cases of sudden and recurrent hearing losses which might coincidently follow vaccination. We report the first case, to our knowledge, of systemic and local steroid administration to successfully treat sudden and recurrent left-ear hearing loss, respectively, following a second dose of the BNT162b2 COVID-19 mRNA vaccination which inflammatory response potentially affected an existing left intralabyrinthine schwannoma in a young male patient. This case highlights the importance and timing of intratympanic steroid treatment strategies to suppress the progressive symptoms and restore hearing to a stable condition, and therefore avoid permanent hearing loss which would otherwise demand a surgical removal of the schwannoma to improve vertigo and reconstitute artificial hearing.